evenfolioETF Details
T. Rowe·Health·TDNA · Nasdaq
T. Rowe Price Biotech ETF (TDNA)
- Price
- $25.18
- —21 Sept 2026
- Assets
- —
- Total net assets
- Expense ratio
- —
- Per year
- Yield
- —
- Trailing distributions
- 1Y return
- —
- Category 35.2%
- 3Y CAGR
- —
- Category 16.3%
- 5Y CAGR
- —
- Category 2.6%
Loading NAV history…
T. Rowe Price Biotech ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | — | — | — | — | — | — | — | — | -1.2% |
| Health average | -3.3% | 13.5% | 24.9% | 17.3% | 35.2% | 16.3% | 2.6% | 9.2% | 11.1% |
| Difference | — | — | — | — | — | — | — | — | -12.3% |
Holdings
This ETF publishes no holdings breakdown.
ETF details
- Issuer
- T. Rowe
- Category
- Equity · Health
- Ticker
- TDNA
- Exchange
- Nasdaq
- Inception
- 17 Sept 2026 (0.0 years)
- Structure
- Exchange traded fund
- Expense ratio
- —
- Distribution yield
- —
- Total net assets
- —
Prices and returns as of 21 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XLV · State Street Health Care Select Sector SPDR ETFState Street Investment Management · $43.9B · ER 0.08%5Y 6.9%
- VHT · Vanguard Health Care ETFVanguard · $22B · ER 0.09%5Y 6.0%
- XBI · State Street SPDR S&P Biotech ETFState Street Investment Management · $11.4B · ER 0.35%5Y 4.1%
- IBB · iShares Biotechnology ETFiShares · $10.5B · ER 0.44%5Y 4.1%
- IXJ · iShares Global Healthcare ETFiShares · $4.3B · ER 0.38%5Y 5.0%
- IYH · iShares U.S. Healthcare ETFiShares · $3.9B · ER 0.37%5Y 5.9%